Request Demo
Recent blog posts
Latest Hotspot
8 min read
HDAC1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
HDAC1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
TOP2A Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
TOP2A target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
TOP1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
TOP1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
AURKA Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
AURKA target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
ERBB3 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
ERBB3 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
FGFR4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
FGFR4 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
FGFR1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
FGFR1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
HSP90AA1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
HSP90AA1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
MAPK1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
MAPK1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
MAP2K1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
MAP2K1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
AKT1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
AKT1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
TREM2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
This TREM2 Target Evaluation Report is generated from PatSnap MCP data. TREM2 has an appealing macrophage-reprogramming idea, but the clinical record is thin and both retrieved solid-tumor trials were terminated. This should be read as a cautious target, not a validated opportunity.